An observational study in Tachycardia, Paroxysmal Supraventricular Tachycardia and Wolff-Parkinson-White Syndrome, sponsored by Inha University Hospital. Recruiting at 1 site in South Korea. Open to participants aged 19 Years and older. Per ClinicalTrials.gov, last updated 2026-10-30.
Sponsored by Inha University Hospital · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
This multicenter retrospective study aims to develop, validate, and clinically apply an artificial intelligence (AI)-powered electrocardiography (ECG) algorithm for the diagnosis and prognostic prediction of cardiovascular diseases, including coronary artery disease and heart failure. By utilizing encrypted raw 12-lead ECG text data and deep neural network models, the study evaluates the effectiveness of AI-enhanced ECG in detecting cardiac abnormalities and predicting clinical outcomes.
452 studies on the registry are indexed under Tachycardia, Ventricular; 121 are open to participants now.
This study's planned enrollment of 10,000 is above the median of 167 across 147 observational studies indexed under Tachycardia, Ventricular.
Browse Tachycardia, Ventricular studies →Inha University Hospital is the lead sponsor of 37 studies on the registry; 8 are open to participants now.
Compared within Tachycardia, Ventricular, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Tachycardia. The counts are of registry records indexed under each term, refreshed daily. How we classify →
The criteria were revised on the registry on Oct 30, 2026. See what changed
Retrospective cohort of patients aged 19 years or older with PSVT, WPW syndrome, PVC, or VT who underwent electrophysiological study and catheter ablation at participating institutions between January 2005 and December 2023.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A recording of the heart’s electrical activity, taken with stickers on the chest, arms and legs. It takes a few minutes and does not hurt.
ECG (electrocardiogram)
A recording of the heart’s electrical activity, taken with stickers on the chest, arms and legs. It takes a few minutes and does not hurt.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Patients aged 19 years or older diagnosed with tachycardias (including PSVT, WPW syndrome, PVC, or VT) who underwent an electrophysiological study (EPS) and radiofrequency catheter ablation (RFCA), with extractable 12-lead ECG text data\[cite: 1\].
Diagnostic Test: AI-based ECG Diagnostic and Localization Algorithm
Application of a deep learning-based 12-lead electrocardiogram (ECG) algorithm to analyze raw text data for the differential diagnosis and localization of tachycardias, including PSVT, WPW syndrome, PVC, and VT\[cite: 1\].
Area Under the ROC Curve (AUC) of AI-ECG Models for Differentiating Tachycardia Mechanisms Confirmed by Electrophysiological Study
Diagnostic performance of Transformer-based deep learning models applied to 12-lead ECG raw data for differentiating tachycardia mechanisms, including atrioventricular nodal reentrant tachycardia (AVNRT) versus atrioventricular reentrant tachycardia (AVRT). The reference standard is the diagnosis confirmed by electrophysiological study and catheter ablation. Performance is summarized as AUC with 95% confidence interval (range 0-1; higher values indicate better discrimination).
Time frame: Baseline
Area Under the ROC Curve (AUC) of AI-ECG Models for Localizing Arrhythmia Origin Sites (Accessory Pathway, PVC, and VT) Confirmed by Successful Catheter Ablation
Performance of AI-ECG models in classifying the anatomical site of the arrhythmia substrate from the pre-ablation 12-lead ECG, including (1) accessory pathway location in Wolff-Parkinson-White syndrome, (2) the origin of premature ventricular contractions, and (3) the origin of ventricular tachycardia. The reference standard is the site identified by electrophysiological mapping and confirmed by successful catheter ablation. For each classification task, performance is reported as AUC with 95% confidence interval (range 0-1; higher values indicate better classification).
Time frame: Baseline
Plan to share: No — Individual participant data (IPD) will not be shared with other researchers due to institutional data privacy policies and ethical regulations concerning retrospective clinical records and encrypted electrocardiogram data.
No publications or documents are linked to this record.
Started Dec 2023 (actual). Primary completion is estimated for Dec 2028, 60 months after the start.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Inha University Hospital